Pharmacytimes: Condition Center: Hepatitis C http://www.pharmacytimes.com/resource-centers/hepatitisc/condition-rss Hepatitis C en-us Tue, 30 Jun 2015 04:56:38 UTC Tue, 30 Jun 2015 04:56:38 UTC Prescription Payment Caps Enacted in California http://www.pharmacytimes.com/news/Prescription-Payment-Caps-Enacted-in-California California’s Affordable Care Act health insurance exchange marketplace is the first in the nation to enact a payment cap policy for expensive specialty drugs. Mon, 29 Jun 2015 03:51:00 UTC New Drugs Health-System Pharmacists Should Know http://www.pharmacytimes.com/news/New-Drugs-Health-System-Pharmacists-Should-Know Here are new drugs for 2015 pharmacists can expect to handle. Thu, 18 Jun 2015 04:26:00 UTC Pharmacists Need to Weigh Cost–Benefit of Chronic Hepatitis C Drugs http://www.pharmacytimes.com/news/Pharmacists-Need-to-Weigh-CostBenefit-of-Chronic-Hepatitis-C-Drugs High costs associated with new chronic hepatitis C virus (HCV) treatments should prompt pharmacists to reconsider their formula for determining the drugs’ worth. Mon, 15 Jun 2015 03:30:00 UTC Costly Hepatitis C Drugs Pose Pharmacy Budget Problems for Prisons http://www.pharmacytimes.com/news/Costly-Hepatitis-C-Drugs-Pose-Pharmacy-Budget-Problems-for-Prisons Treating prisoners for hepatitis C virus can be a costly nightmare, straining prisons’ pharmacy and health care budgets. Sun, 12 Apr 2015 05:00:00 UTC New Hepatitis C Regimens Have Adherence Issues http://www.pharmacytimes.com/news/New-Hepatitis-C-Regimens-Have-Adherence-Issues Advances in treatment for chronic hepatitis C virus have been breaking news in the last few years. Wed, 01 Apr 2015 03:00:00 UTC Researchers Identify How Hepatitis Leads to Liver Cancer http://www.pharmacytimes.com/news/Researchers-Identify-How-Hepatitis-Leads-to-Liver-Cancer A recent study has identified how chronic hepatitis infection can pave the way to liver cancer. Fri, 06 Feb 2015 04:18:00 UTC How Hepatitis C Therapies are Changing Patient Treatment http://www.pharmacytimes.com/interviews/How-Hepatitis-C-Therapies-are-Changing-Patient-Treatment Eric Tichy, PharmD, BCPS, FCCP, senior clinical pharmacy specialist at Yale New-Haven Hospital, explains how hepatitis C therapies are changing patient treatment. Sat, 10 Jan 2015 02:18:00 UTC More Awareness of Hepatitis C Patients Needed http://www.pharmacytimes.com/news/More-Awareness-of-Hepatitis-C-Patients-Needed A new study has revealed that many patients infected with the hepatitis C virus do not seek treatment and become lost in the different stages of health care to manage the disease. Wed, 24 Dec 2014 01:32:55 UTC Researchers Set to Study Hepatitis C Therapy in Children http://www.pharmacytimes.com/news/Researchers-Set-to-Study-Hepatitis-C-Therapy-in-Children Researchers from Saint Louis University Medical Center will test the safety and efficacy of sofosbuvir and ribavirin in children with hepatitis C. Sat, 04 Oct 2014 01:40:59 UTC Polypharmacy Hinders HIV Drug Adherence http://www.pharmacytimes.com/news/Polypharmacy-Hinders-HIV-Drug-Adherence Among HIV-positive patients, concurrent use of medications is associated with nonadherence to antiretroviral therapy. Sat, 27 Sep 2014 04:33:01 UTC Combination Treatment for HIV/HCV Coinfection Shown Effective in Phase 3 Trial http://www.pharmacytimes.com/news/Combination-Treatment-for-HIVHCV-Coinfection-Shown-Effective-in-Phase-3-Trial Results of a phase 3 trial demonstrate the effectiveness of simeprevir in combination with ribavirin and peginterferon as a treatment for patients coinfected with HIV and HCV. Tue, 16 Sep 2014 02:56:43 UTC Hepatitis C Patients with HIV Co-Infection Vulnerable to Serious Liver Disease Despite Antiretroviral Therapy http://www.pharmacytimes.com/news/Hepatitis-C-Patients-with-HIV-Co-Infection-Vulnerable-to-Serious-Liver-Disease-Despite-Antiretroviral-Therapy A study finds that patients co-infected with hepatitis C and HIV who are receiving antiretroviral therapy are 80% more likely to have serious liver disease than those with hepatitis C alone. Fri, 23 May 2014 01:00:54 UTC Multiple Tactics Needed to Combat Hepatitis C in Young Drug Users http://www.pharmacytimes.com/news/Multiple-Tactics-Needed-to-Combat-Hepatitis-C-in-Young-Drug-Users With hepatitis C infections on the rise among young injection drug users, researchers have recommended a range of promising prevention tactics. Wed, 07 Aug 2013 04:16:31 UTC Task Force Recommends Hepatitis C Testing for Baby Boomers http://www.pharmacytimes.com/news/Task-Force-Recommends-Hepatitis-C-Testing-for-Baby-Boomers The U.S. Preventive Services Task Force recommends that all patients born between 1945 and 1965 as well as high-risk patients of all ages be tested for hepatitis C. Tue, 09 Jul 2013 07:57:10 UTC CDC Urges All Baby Boomers to Get Tested for Hepatitis C http://www.pharmacytimes.com/news/CDC-Urges-All-Baby-Boomers-to-Get-Tested-for-Hepatitis-C Testing baby boomers could help identify more than 800,000 new cases of hepatitis C and address the largely preventable consequences of the condition. Fri, 08 Jun 2012 04:46:49 UTC Triple Therapy for Hepatitis C Can Be Cost-Effective http://www.pharmacytimes.com/news/Triple-Therapy-for-Hepatitis-C-Can-Be-Cost-Effective New triple-therapy regimens for hepatitis C are expensive, but they can be cost-effective for many patients. Mon, 27 Feb 2012 05:20:09 UTC Risk Factors for Hepatitis C http://www.pharmacytimes.com/podcasts/Risk-Factors-for-Hepatitis-C Fri, 24 Feb 2012 06:43:17 UTC New Drugs for Hepatitis C http://www.pharmacytimes.com/podcasts/New-Drugs-for-Hepatitis-C Fri, 24 Feb 2012 06:27:22 UTC The Promise of Interferon-Free Treatment Regimens for Hepatitis C http://www.pharmacytimes.com/podcasts/The-Promise-of-Interferon-Free-Treatment-Regimens-for-Hepatitis-C Fri, 24 Feb 2012 05:37:42 UTC New Hepatitis C Treatment http://www.pharmacytimes.com/interviews/New-Hepatitis-C-Treatment Fri, 24 Feb 2012 04:53:59 UTC